HUP0103228A3 - Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents and pharmaceutical compositions containing them - Google Patents

Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents and pharmaceutical compositions containing them

Info

Publication number: HUP0103228A3
Authority: HU; Hungary
Prior art keywords: alkynyl; pharmaceutical compositions; compositions containing; anticancer agents; derivatives useful
Prior art date: 1998-08-27

Application number

HU0103228A

Other languages

English (en)

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-27

Filing date

1999-08-06

Publication date

2003-01-28

1999-08-06 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2002-02-28 Publication of HUP0103228A2 publication Critical patent/HUP0103228A2/hu

2003-01-28 Publication of HUP0103228A3 publication Critical patent/HUP0103228A3/hu

Links

239000002246 antineoplastic agent Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

HU0103228A 1998-08-27 1999-08-06 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents and pharmaceutical compositions containing them HUP0103228A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US9814598P	1998-08-27	1998-08-27
PCT/IB1999/001398 WO2000012499A1 (en)	1998-08-27	1999-08-06	Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents

Publications (2)

Publication Number	Publication Date
HUP0103228A2 HUP0103228A2 (hu)	2002-02-28
HUP0103228A3 true HUP0103228A3 (en)	2003-01-28

Family

ID=22267481

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0103228A HUP0103228A3 (en)	1998-08-27	1999-08-06	Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents and pharmaceutical compositions containing them

Country Status (40)

Country	Link
US (3)	US6150377A (hu)
EP (1)	EP1107963B1 (hu)
JP (1)	JP3495706B2 (hu)
KR (1)	KR20010072991A (hu)
CN (1)	CN1314904A (hu)
AP (1)	AP2001002079A0 (hu)
AT (1)	ATE321037T1 (hu)
AU (1)	AU4925499A (hu)
BG (1)	BG105365A (hu)
BR (1)	BRPI9913138B8 (hu)
CA (2)	CA2341690C (hu)
CO (1)	CO5130017A1 (hu)
CZ (1)	CZ2001660A3 (hu)
DE (1)	DE69930518T2 (hu)
DZ (1)	DZ2880A1 (hu)
EA (1)	EA200100135A1 (hu)
EE (1)	EE200100118A (hu)
ES (1)	ES2259237T3 (hu)
GE (1)	GEP20033001B (hu)
GT (1)	GT199900140A (hu)
HK (1)	HK1039123A1 (hu)
HR (1)	HRP20010142A2 (hu)
HU (1)	HUP0103228A3 (hu)
ID (1)	ID27562A (hu)
IL (1)	IL141239A0 (hu)
IS (1)	IS5818A (hu)
MA (1)	MA26680A1 (hu)
NO (1)	NO20010964L (hu)
NZ (1)	NZ509372A (hu)
OA (1)	OA11645A (hu)
PA (1)	PA8480101A1 (hu)
PE (1)	PE20000986A1 (hu)
PL (1)	PL346426A1 (hu)
SK (1)	SK2442001A3 (hu)
SV (1)	SV1999000141A (hu)
TN (1)	TNSN99162A1 (hu)
TR (1)	TR200101343T2 (hu)
UY (1)	UY25682A1 (hu)
WO (1)	WO2000012499A1 (hu)
ZA (1)	ZA200101173B (hu)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030114503A1 (en) *	1997-06-16	2003-06-19	Pfizer Inc.	Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the treatment of cancer
ID27199A (id) *	1998-07-06	2001-03-08	Janssen Pharmaceutica Nv	Penghambat transferase protein farnesil untuk pengobatan artropatis
JP3494409B2 (ja) *	1998-08-27	2004-02-09	ファイザー・プロダクツ・インク	抗がん剤として有用なアルキニル置換キノリン−２−オン誘導体
SK2442001A3 (en) *	1998-08-27	2002-10-08	Pfizer Prod Inc	Alkynyl-substituted quinolin-2-ones, pharmaceutical compositions, their use in the treatment and method for producing thereof
TR200201297T2 (tr)	1999-02-11	2002-06-21	Pfizer Products Inc.	Antikanser maddeleri olarak faydalı heteroaril-ikame edilmiş kinolin-2-on türevleri.
HN2000000266A (es)	2000-01-21	2001-05-21	Pfizer Prod Inc	Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
EP1267848B1 (en)	2000-02-24	2007-10-17	Janssen Pharmaceutica N.V.	Dosing regimen comprising a farnesyl protein transferase inhibitor for the treatment of cancer
JO2361B1 (en)	2000-06-22	2006-12-12	جانسين فارماسيوتيكا ان. في	Enaniumer 1,2-anylated quinoline inhibitor for the transporter - farnesyl
US7173040B2 (en)	2000-09-25	2007-02-06	Janssen Pharmaceutica N.V.	Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derinazoline derivatives
JP4974439B2 (ja) *	2000-09-25	2012-07-11	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	ファルネシルトランスフェラーゼを阻害する６−ヘテロシクリルメチルキノリノン誘導体
AU2002220559A1 (en)	2000-09-25	2002-04-02	Janssen Pharmaceutica N.V.	Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
EP1322635B1 (en)	2000-09-25	2006-03-22	Janssen Pharmaceutica N.V.	Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
DE60139080D1 (de)	2000-11-21	2009-08-06	Janssen Pharmaceutica Nv	Farnesyltransferase hemmende benzoheterocyclische derivate
MXPA03005525A (es) *	2000-12-19	2003-10-06	Pfizer Prod Inc	Formas cristalinas de sales de 2,3-dihidroxibutanodioato de 6-[(4-cloro -fenil)- hidroxi-(3 -metil-3h-imidazol -4-il)-metil] -4-(3-etinil-fenil) -1-metil-1h -quinolein-2 -ona, y metodo de produccion.
US7129356B2 (en)	2000-12-27	2006-10-31	Janssen Pharmaceutica N.V.	Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
AU2002236813A1 (en) *	2001-01-22	2002-07-30	Schering Corporation	Treatment of malaria with farnesyl protein transferase inhibitors
DK1373255T3 (da) *	2001-03-12	2005-05-23	Janssen Pharmaceutica Nv	Fremgangsmåde til fremstilling af imidazolforbindelser
US20020151563A1 (en) *	2001-03-29	2002-10-17	Pfizer Inc.	Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the inhibition of abnormal cell growth
WO2002080895A2 (en) *	2001-04-06	2002-10-17	Schering Corporation	Treatment of malaria with farsenyl protein transferase inhibitors
WO2002098425A1 (en) *	2001-06-04	2002-12-12	Cytovia, Inc.	Substituted 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP1408971A4 (en)	2001-06-21	2006-01-25	Ariad Pharma Inc	NEW QUINOLINES AND THEIR USES
US6740757B2 (en) *	2001-08-29	2004-05-25	Pfizer Inc	Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer
WO2003051880A1 (en)	2001-12-19	2003-06-26	Janssen Pharmaceutica N.V.	1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors
ES2287466T3 (es)	2002-03-22	2007-12-16	Janssen Pharmaceutica N.V.	Derivados de 2-quinolinona y quinazolina de bencilimidazolil sustituidas como inhibidores de la farnesil transferasa.
ATE336496T1 (de)	2002-04-15	2006-09-15	Janssen Pharmaceutica Nv	Farnesyl transferase hemmende tricyclische quinazolinederivate substitutiert mit kohlenstoff-gebundenen imidazolen oder triazolen
EA008501B1 (ru) *	2002-12-19	2007-06-29	Пфайзер Инк.	2-(1н-индазол-6-иламино)бензамидные соединения как ингибиторы протеинкиназ, полезные для лечения офтальмологических заболеваний
JP4691041B2 (ja)	2003-11-20	2011-06-01	チルドレンズホスピタルメディカルセンター	Ｇｔｐアーゼ阻害剤および使用方法
WO2005089515A2 (en) *	2004-03-18	2005-09-29	The Brigham And Women's Hospital, Inc.	Methods for the treatment of synucleinopathies
BRPI0509580A (pt) *	2004-03-30	2007-11-27	Pfizer Prod Inc	combinações de inibidores de transdução de sinal
EP1786777A1 (en) *	2004-08-26	2007-05-23	Pfizer, Inc.	Aminoheteroaryl compounds as protein tyrosine kinase inhibitors
KR100859891B1 (ko) *	2004-08-26	2008-09-23	화이자 인코포레이티드	단백질 키나제 억제제로서 거울상이성질체적으로 순수한아미노헤테로아릴 화합물
ES2355923T3 (es) *	2004-08-26	2011-04-01	Pfizer, Inc.	Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa.
DK2362218T3 (en)	2004-11-05	2014-11-17	Janssen Pharmaceutica Nv	Methods for monitoring the effectiveness of farnesyl transferase
US20060107555A1 (en) *	2004-11-09	2006-05-25	Curtis Marc D	Universal snow plow adapter
US20060281788A1 (en)	2005-06-10	2006-12-14	Baumann Christian A	Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
CA2617056A1 (en)	2005-07-29	2007-02-08	Children's Hospital Medical Center	Gtpase inhibitors and methods of use and crystal structure of rac-1 gtpase
PE20080035A1 (es)	2005-09-07	2008-01-30	Amgen Fremont Inc	Anticuerpos monoclonales humanos para la quinasa-1 tipo receptor de activina
DK1926996T3 (da)	2005-09-20	2012-01-23	Osi Pharmaceuticals Llc	Biologiske markører, som er prædiktive for anti-cancer-reaktion på insulinlignende vækstfaktor-1-receptorkinasehæmmere
WO2007075923A2 (en)	2005-12-23	2007-07-05	Link Medicine Corporation	Treatment of synucleinopathies
TW200812615A (en)	2006-03-22	2008-03-16	Hoffmann La Roche	Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2
US8697716B2 (en)	2006-04-20	2014-04-15	Janssen Pharmaceutica Nv	Method of inhibiting C-KIT kinase
ATE510832T1 (de)	2006-04-20	2011-06-15	Janssen Pharmaceutica Nv	Heterocyclische verbindungen als c-fms- kinasehemmer
BRPI0710548B8 (pt)	2006-04-20	2021-05-25	Janssen Pharmaceutica Nv	inibidores de c-fms cinase, composição farmacêutica e forma de dosagem farmacêutica
AU2007251282A1 (en)	2006-05-09	2007-11-22	Pfizer Products Inc.	Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
NZ574580A (en)	2006-08-21	2011-12-22	Hoffmann La Roche	Her2 tumor therapy with an anti-vegf antibody
WO2008112525A2 (en) *	2007-03-09	2008-09-18	Link Medicine Corporation	Treatment of lysosomal storage diseases
JO3240B1 (ar)	2007-10-17	2018-03-08	Janssen Pharmaceutica Nv	c-fms مثبطات كيناز
WO2009151683A2 (en)	2008-03-12	2009-12-17	Link Medicine Corporation	Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
DE102008022221A1 (de) *	2008-05-06	2009-11-12	Universität des Saarlandes	Inhibitoren der humanen Aldosteronsynthase CYP11B2
US20100331363A1 (en) *	2008-11-13	2010-12-30	Link Medicine Corporation	Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
AU2009313927A1 (en)	2008-11-13	2010-05-20	Astrazeneca Ab	Azaquinolinone derivatives and uses thereof
US20110060005A1 (en) *	2008-11-13	2011-03-10	Link Medicine Corporation	Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
WO2010099139A2 (en)	2009-02-25	2010-09-02	Osi Pharmaceuticals, Inc.	Combination anti-cancer therapy
EP2400990A2 (en)	2009-02-26	2012-01-04	OSI Pharmaceuticals, LLC	In situ methods for monitoring the emt status of tumor cells in vivo
WO2010099138A2 (en)	2009-02-27	2010-09-02	Osi Pharmaceuticals, Inc.	Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
WO2010099364A2 (en)	2009-02-27	2010-09-02	Osi Pharmaceuticals, Inc.	Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
EP2401614A1 (en)	2009-02-27	2012-01-04	OSI Pharmaceuticals, LLC	Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
US20110275644A1 (en)	2010-03-03	2011-11-10	Buck Elizabeth A	Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
EP2542893A2 (en)	2010-03-03	2013-01-09	OSI Pharmaceuticals, LLC	Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
US20120214830A1 (en)	2011-02-22	2012-08-23	OSI Pharmaceuticals, LLC	Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors in hepatocellular carcinoma
WO2012149014A1 (en)	2011-04-25	2012-11-01	OSI Pharmaceuticals, LLC	Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment
WO2013152252A1 (en)	2012-04-06	2013-10-10	OSI Pharmaceuticals, LLC	Combination anti-cancer therapy
WO2013166043A1 (en)	2012-05-02	2013-11-07	Children's Hospital Medical Center	Rejuvenation of precursor cells
AU2013299922B2 (en)	2012-08-07	2018-06-21	Janssen Pharmaceutica Nv	Process for the preparation of heterocyclic ester derivatives
JOP20180012A1 (ar)	2012-08-07	2019-01-30	Janssen Pharmaceutica Nv	عملية السلفنة باستخدام نونافلوروبوتانيسولفونيل فلوريد
AR094403A1 (es)	2013-01-11	2015-07-29	Hoffmann La Roche	Terapia de combinación de anticuerpos anti-her3
US10028503B2 (en)	2014-06-18	2018-07-24	Children's Hospital Medical Center	Platelet storage methods and compositions for same
PT3640345T (pt)	2015-08-17	2021-12-29	Kura Oncology Inc	Métodos de tratamento de doentes com cancro usando inibidores da farnesiltransferase
CN108601752A (zh)	2015-12-03	2018-09-28	安吉奥斯医药品有限公司	用于治疗mtap缺失型癌症的mat2a抑制剂
US20190119758A1 (en)	2016-04-22	2019-04-25	Kura Oncology, Inc.	Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
DK3534885T3 (da)	2016-11-03	2021-04-12	Kura Oncology Inc	Farnesyltransferase-inhibitorer til anvendelse i behandling af kræft
US11471538B2 (en)	2017-02-10	2022-10-18	INSERM (Institut National de la Santéet de la Recherche Medicale)	Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the MAPK pathway
US10137121B2 (en)	2017-02-21	2018-11-27	Kura Oncology, Inc.	Methods of treating cancer with farnesyltransferase inhibitors
EP3432883B1 (en)	2017-02-21	2021-07-28	Kura Oncology, Inc.	Methods of treating cancer with farnesyltransferase inhibitors
US10806730B2 (en)	2017-08-07	2020-10-20	Kura Oncology, Inc.	Methods of treating cancer with farnesyltransferase inhibitors
MY200746A (en)	2017-08-07	2024-01-13	Kura Oncology Inc	Methods of treating cancer with farnesyltransferase inhibitors
WO2019113269A1 (en)	2017-12-08	2019-06-13	Kura Oncology, Inc.	Methods of treating cancer patients with farnesyltransferase inhibitors
CA3117968A1 (en)	2018-11-01	2020-05-07	Kura Oncology, Inc.	Methods of treating cancer with farnesyltransferase inhibitors
CA3124616A1 (en)	2018-12-21	2020-06-25	Kura Oncology, Inc.	Therapies for squamous cell carcinomas
US20220142983A1 (en)	2019-03-01	2022-05-12	Kura Oncology, Inc.	Methods of treating cancer with farnesyltransferase inhibitors
WO2020190604A1 (en)	2019-03-15	2020-09-24	Kura Oncology, Inc.	Methods of treating cancer patients with farnesyltransferase inhibitors
CN113795253A (zh)	2019-03-29	2021-12-14	库拉肿瘤学公司	用法呢基转移酶抑制剂治疗鳞状细胞癌的方法
TW202102218A (zh)	2019-04-01	2021-01-16	美商庫拉腫瘤技術股份有限公司	以法呢基(farnesyl)轉移酶抑制劑治療癌症的方法
US20220305001A1 (en)	2019-05-02	2022-09-29	Kura Oncology, Inc.	Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors
WO2021155006A1 (en)	2020-01-31	2021-08-05	Les Laboratoires Servier Sas	Inhibitors of cyclin-dependent kinases and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5747498A (en) *	1996-05-28	1998-05-05	Pfizer Inc.	Alkynyl and azido-substituted 4-anilinoquinazolines
TW349948B (en) *	1995-10-31	1999-01-11	Janssen Pharmaceutica Nv	Farnesyl transferase inhibiting 2-quinolone derivatives
TR199800825T2 (xx) *	1995-12-08	1998-08-21	Janssen Pharmaceutica N.V.	Farnesil protein transferini inhibe eden (imidazol-5-il) metil-2-kinolinon t�revleri.
SK2442001A3 (en) *	1998-08-27	2002-10-08	Pfizer Prod Inc	Alkynyl-substituted quinolin-2-ones, pharmaceutical compositions, their use in the treatment and method for producing thereof

1999
- 1999-08-06 SK SK244-2001A patent/SK2442001A3/sk unknown
- 1999-08-06 NZ NZ509372A patent/NZ509372A/en unknown
- 1999-08-06 CN CN99810204A patent/CN1314904A/zh active Pending
- 1999-08-06 GE GEAP19995770A patent/GEP20033001B/en unknown
- 1999-08-06 OA OA1200100051A patent/OA11645A/en unknown
- 1999-08-06 TR TR2001/01343T patent/TR200101343T2/xx unknown
- 1999-08-06 EE EEP200100118A patent/EE200100118A/xx unknown
- 1999-08-06 EP EP99933084A patent/EP1107963B1/en not_active Expired - Lifetime
- 1999-08-06 AP APAP/P/2001/002079A patent/AP2001002079A0/en unknown
- 1999-08-06 IL IL14123999A patent/IL141239A0/xx unknown
- 1999-08-06 ES ES99933084T patent/ES2259237T3/es not_active Expired - Lifetime
- 1999-08-06 EA EA200100135A patent/EA200100135A1/ru unknown
- 1999-08-06 ID IDW20010457A patent/ID27562A/id unknown
- 1999-08-06 HU HU0103228A patent/HUP0103228A3/hu unknown
- 1999-08-06 AU AU49254/99A patent/AU4925499A/en not_active Abandoned
- 1999-08-06 CA CA002341690A patent/CA2341690C/en not_active Expired - Fee Related
- 1999-08-06 BR BRPI9913138A patent/BRPI9913138B8/pt not_active IP Right Cessation
- 1999-08-06 CZ CZ2001660A patent/CZ2001660A3/cs unknown
- 1999-08-06 DE DE69930518T patent/DE69930518T2/de not_active Expired - Lifetime
- 1999-08-06 WO PCT/IB1999/001398 patent/WO2000012499A1/en not_active Application Discontinuation
- 1999-08-06 JP JP2000567527A patent/JP3495706B2/ja not_active Expired - Fee Related
- 1999-08-06 CA CA002578326A patent/CA2578326C/en not_active Expired - Fee Related
- 1999-08-06 AT AT99933084T patent/ATE321037T1/de not_active IP Right Cessation
- 1999-08-06 KR KR1020017002442A patent/KR20010072991A/ko not_active Application Discontinuation
- 1999-08-06 PL PL99346426A patent/PL346426A1/xx not_active Application Discontinuation
- 1999-08-10 PA PA19998480101A patent/PA8480101A1/es unknown
- 1999-08-24 GT GT199900140A patent/GT199900140A/es unknown
- 1999-08-25 MA MA25743A patent/MA26680A1/fr unknown
- 1999-08-25 DZ DZ990180A patent/DZ2880A1/xx active
- 1999-08-25 TN TNTNSN99162A patent/TNSN99162A1/fr unknown
- 1999-08-26 US US09/383,755 patent/US6150377A/en not_active Expired - Lifetime
- 1999-08-26 PE PE1999000862A patent/PE20000986A1/es not_active Application Discontinuation
- 1999-08-27 UY UY25682A patent/UY25682A1/es unknown
- 1999-08-27 CO CO99054519A patent/CO5130017A1/es unknown
- 1999-08-27 SV SV1999000141A patent/SV1999000141A/es not_active Application Discontinuation
2000
- 2000-07-27 US US09/628,039 patent/US6294552B1/en not_active Expired - Lifetime
2001
- 2001-01-19 IS IS5818A patent/IS5818A/is unknown
- 2001-02-12 ZA ZA200101173A patent/ZA200101173B/en unknown
- 2001-02-26 NO NO20010964A patent/NO20010964L/no not_active Application Discontinuation
- 2001-02-27 HR HR20010142A patent/HRP20010142A2/hr not_active Application Discontinuation
- 2001-03-20 BG BG105365A patent/BG105365A/xx unknown
- 2001-07-06 US US09/900,401 patent/US6579887B2/en not_active Expired - Fee Related
2002
- 2002-01-25 HK HK02100579.7A patent/HK1039123A1/zh unknown

Also Published As

Publication number	Publication date
BR9913138B1 (pt)	2013-11-05
NO20010964L (no)	2001-04-26
KR20010072991A (ko)	2001-07-31
CO5130017A1 (es)	2002-02-27
EA200100135A1 (ru)	2001-08-27
US6294552B1 (en)	2001-09-25
ID27562A (id)	2001-04-12
JP2002523504A (ja)	2002-07-30
US20020128287A1 (en)	2002-09-12
IS5818A (is)	2001-01-19
US6579887B2 (en)	2003-06-17
EP1107963A1 (en)	2001-06-20
BG105365A (en)	2001-11-30
EE200100118A (et)	2002-06-17
AU4925499A (en)	2000-03-21
TR200101343T2 (tr)	2001-09-21
SK2442001A3 (en)	2002-10-08
ATE321037T1 (de)	2006-04-15
DE69930518D1 (de)	2006-05-11
JP3495706B2 (ja)	2004-02-09
HUP0103228A2 (hu)	2002-02-28
CA2578326C (en)	2009-11-24
PE20000986A1 (es)	2000-09-30
UY25682A1 (es)	2000-03-31
CZ2001660A3 (cs)	2002-05-15
TNSN99162A1 (fr)	2005-11-10
CA2341690A1 (en)	2000-03-09
NZ509372A (en)	2003-08-29
WO2000012499A1 (en)	2000-03-09
CN1314904A (zh)	2001-09-26
DE69930518T2 (de)	2006-09-21
ES2259237T3 (es)	2006-09-16
DZ2880A1 (fr)	2003-12-15
SV1999000141A (es)	2000-07-06
EP1107963B1 (en)	2006-03-22
ZA200101173B (en)	2002-04-12
HRP20010142A2 (en)	2002-02-28
CA2341690C (en)	2007-04-17
AP2001002079A0 (en)	2001-03-31
GEP20033001B (en)	2003-06-25
NO20010964D0 (no)	2001-02-26
IL141239A0 (en)	2002-03-10
MA26680A1 (fr)	2004-12-20
CA2578326A1 (en)	2000-03-09
OA11645A (en)	2004-11-16
PA8480101A1 (es)	2003-06-30
BRPI9913138B8 (pt)	2016-05-17
GT199900140A (es)	2001-02-14
HK1039123A1 (zh)	2002-04-12
BR9913138A (pt)	2001-05-08
PL346426A1 (en)	2002-02-11
US6150377A (en)	2000-11-21

Legal Events

Date	Code	Title	Description
2007-05-29	FD9A	Lapse of provisional protection due to non-payment of fees

Publication	Publication Date	Title
HUP0103228A3 (en)	2003-01-28	Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents and pharmaceutical compositions containing them
EG24066A (en)	2008-05-08	Novel quinuclidine derivatives and medicinal compositions containing the same
IL146540A0 (en)	2002-07-25	Thiazolo derivatives and pharmaceutical compositions containing them
HUP0105231A3 (en)	2003-01-28	Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents and medicaments containing the compounds
IL138899A0 (en)	2001-11-25	Amidene derivatives and pharmaceutical compositions containing the same
HUP0103406A3 (en)	2002-11-28	1h-imidazopyridine derivatives and pharmaceutical compositions thereof
IL135986A0 (en)	2001-05-20	Chrysamine g derivatives and pharmaceutical and diagnostic compositions containing the same
IL140862A (en)	2005-05-17	Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
HUP0102990A3 (en)	2002-09-30	Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
IL123036A0 (en)	1998-09-24	8-substituted-1,3,8-triaza-spiro Ú4,5¾ decan-4-on derivatives their preparation and pharmaceutical compositions containing them
IL143920A0 (en)	2002-04-21	3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
IL114492A0 (en)	1995-11-27	Benzimidazole derivatives their preparation and pharmaceutical compositions containing them
HUP0200588A2 (hu)	2002-07-29	Diarilszármazékok és azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0202788A3 (en)	2003-02-28	Indolyl-3-glyoxylic acid derivatives serving as antitumor agents and pharmaceutical compositions containing them
HUP0101381A3 (en)	2002-06-28	Benzofurylpyrone derivatives and pharmaceutical compositions containing them
IL125710A0 (en)	1999-04-11	Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them
IL138572A0 (en)	2001-10-31	Benzoate derivatives and pharmaceutical compositions containing the same
IL155067A0 (en)	2003-10-31	(dihydro) isoquinoline derivatives and pharmaceutical compositions containing the same
IL147214A0 (en)	2002-08-14	1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
HUP0105204A3 (en)	2002-05-28	Substituted phenethylamine derivatives and pharmaceutical compositions containing them
HUP0002324A3 (en)	2001-07-30	Benzimidazole derivatives and pharmaceutical compositions containing them
HUP0103203A3 (en)	2002-10-28	Azaadamantane derivatives and pharmaceutical compositions thereof
IL137415A0 (en)	2001-07-24	Cyclobutene derivatives and pharmaceutical compositions containing the same
IL148807A0 (en)	2002-09-12	Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same
AP2001002371A0 (en)	2001-12-31	Streptogramin derivatives preparation and compositions containing them